BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 30, 2011
View Archived Issues
SK Biopharmaceuticals divulges preclinical data on SKL-A4R
Read More
Novartis discloses final results from EXIST-2 trial
Read More
Data presented from phase I trial of OPB-31121 in advanced solid malignancies
Read More
FDA accepts Amarin's NDA for AMR-101
Read More
Supernus commences U.S. phase IIb study of SPN-810
Read More
Multi-biomarker panel may monitor clinical disease activity in subjects with RA
Read More
Ongoing trial investigates effects of bevacizumab in neoplastic meningitis
Read More
Scientists at Karus Therapeutics prepare new PI3K inhibitors
Read More
French researchers patent novel kinase inhibitors
Read More
Astex Pharmaceuticals presents novel anticancer compounds
Read More
Phase IIb trial of RVX-208 in high-risk cardiovascular disease completes enrollment
Read More
Proximagen and Altacor enter agreement for serotonin 5-HT2C program
Read More
Cytokinetics begins third phase II trial of CK-2017357 in ALS
Read More
University of Edinburgh discloses new 11-beta-HSD1 inhibitors
Read More
FDA accepts Lodotra NDA for review
Read More
Compugen and DiscoveRx collaborate on novel peptide ligands
Read More
Omeros submits pediatric investigation plan to EMA for OMS-302
Read More
Japanese team synthesizes novel MMP-9 inhibitors
Read More
BMS obtains approval for additional indication for Paraplatin in Japan
Read More
Infinity and Mundipharma extend strategic alliance for PI3K inhibitors
Read More
FDA accepts Eliquis NDA for review
Read More
OncoVista secures CRO for phase Ib study of cordycepin
Read More
BioMarin begins study of GALNS in young patients with MPS IVA
Read More
Provectus gives update on program for PV-10 in metastatic melanoma
Read More
Soliris approved in Europe for treatment atypical hemolytic uremic syndrome
Read More